Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Heparin Market to reach USD 8.62 billion by 2028.

Global Heparin Market Size study, by Type (Low Molecular Weight Heparin, Ultra-low Molecular Weight Heparin, Unfractionated Heparin) by Route of Administration (Intravenous, Subcutaneous) by Application (Venous Thromboembolism, Atrial Fibrillation, Renal Impairment, Coronary Artery Disease, Others) by End-use (Outpatient, Inpatient) by Source (Porcine, Bovine, Others) and Regional Forecasts 2022-2028

Product Code: HLSDT-35013598
Publish Date: 12-07-2022
Page: 200

Global Heparin Market is valued approximately USD 7.3 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 2.4% over the forecast period 2022-2028. Heparin, commonly known as unfractionated heparin, is a glycosaminoglycan that occurs naturally. Heparins are anticoagulants since they rely on the activity of antithrombin. The market is expected to be driven by the rising prevalence of illnesses such as renal impairment, coronary artery disease, and venous thromboembolism. According to the CDC, in 2022, around 900,000 people in the United States may be impacted by venous thromboembolism, which may result in the death of 10% – 30% of persons within one month of diagnosis. Anticoagulant demand is expected to drive the entire industry. Furthermore, growing health-care expenditures and government-led efforts are among the important drivers expected to fuel market expansion. One of the primary reasons driving the overall market is the rising prevalence of chronic illnesses such as cardiovascular disorders and renal diseases. Diabetes prevalence over 30 years was 13.8 percent in 2020, according to the Korea Biomedical, . Diabetes patients are more likely to experience blood coagulation, which can lead to heart disease and renal issues. Heparin’s application in the treatment of such illnesses is expected to fuel market expansion. The COVID-19 epidemic has greatly raised the market between 2020 and 2021. According to the JAMA Journal in 2021, aberrant blood clots are widespread in COVID-19 patients due to clot-promoting autoantibodies, which cause deep vein thrombosis and pulmonary embolisms, opening the door for heparin. According to a 2021 article published in the Journal of the American Heart Association (JAHA), early-stage anticoagulation treatment with low-molecular-weight heparin might better prevent COVID19-associated coagulopathy and endotheliopathy, leading to a better prognosis in a patient. All of the variables mentioned above are projected to contribute to market expansion. However, the side effects of heparin hinder market growth throughout the projection period of 2022-2028.

The key regions considered for the Global Heparin Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America led the market and had the highest revenue share in 2021. This is because cardiovascular problems and injuries are on the rise. Furthermore, rising healthcare expenditure levels and increased patient awareness in this region might be related to the region’s high proportion. The market in Asia Pacific is expected to develop at the quickest rate during the forecast period. Some of the key drivers driving expansion are an ageing population, a big population with chronic disease, and expanding economies. In addition, Asia Pacific is the main source of crude heparin and its API. This benefits local businesses like Pharmax Lifesciences. Local firms are developing low-cost generic versions of patent-expired pharmaceuticals.

Major market player included in this report are:
Pfizer Inc.
LEO Pharma A/S
Dr. Reddy’s Laboratories Ltd.
GlaxoSmithKline plc
Sanofi
Aspen Holdings
Fresenius SE & Co. KGaA
B. Braun Medical, Inc.
Sandoz (Novartis AG)
Baxter International Inc
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Low Molecular Weight Heparin
Ultra-low Molecular Weight Heparin
Unfractionated Heparin
By Source:
Porcine
Bovine
Others

By Route of Administration:
Intravenous
Subcutaneous

By Application:
Venous Thromboembolism
Atrial Fibrillation
Renal Impairment
Coronary Artery Disease
Others

By End-use:
Outpatient
Inpatient

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Heparin Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Heparin Market, by Region, 2020-2028 (USD Billion)
1.2.2. Heparin Market, by Type, 2020-2028 (USD Billion)
1.2.3. Heparin Market, by Source, 2020-2028 (USD Billion)
1.2.4. Heparin Market, by Route of Administration, 2020-2028 (USD Billion)
1.2.5. Heparin Market, by Application, 2020-2028 (USD Billion)
1.2.6. Heparin Market, by End-Use, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Heparin Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Heparin Market Dynamics
3.1. Heparin Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Increasing incidence of diabetes
3.1.1.2. Growing geriatric population
3.1.2. Market Challenges
3.1.2.1. High cost of Heparin
3.1.3. Market Opportunities
3.1.3.1. Advancements in formulation
Chapter 4. Global Heparin Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Heparin Market, by Type
6.1. Market Snapshot
6.2. Global Heparin Market by Type, Performance – Potential Analysis
6.3. Global Heparin Market Estimates & Forecasts by Type 2018-2028 (USD Billion)
6.4. Heparin Market, Sub Segment Analysis
6.4.1. Low Molecular Weight Heparin
6.4.2. Ultra-low Molecular Weight Heparin
6.4.3. Unfractionated Heparin
Chapter 7. Global Heparin Market, by Source
7.1. Market Snapshot
7.2. Global Heparin Market by Source, Performance – Potential Analysis
7.3. Global Heparin Market Estimates & Forecasts by Source 2018-2028 (USD Billion)
7.4. Heparin Market, Sub Segment Analysis
7.4.1. Porcine
7.4.2. Bovine
7.4.3. Others
Chapter 8. Global Heparin Market, by Route of Administration
8.1. Market Snapshot
8.2. Global Heparin Market by Route of Administration, Performance – Potential Analysis
8.3. Global Heparin Market Estimates & Forecasts by Route of Administration 2018-2028 (USD Billion)
8.4. Heparin Market, Sub Segment Analysis
8.4.1. Intravenous
8.4.2. Subcutaneous
Chapter 9. Global Heparin Market, by Application
9.1. Market Snapshot
9.2. Global Heparin Market by Application, Performance – Potential Analysis
9.3. Global Heparin Market Estimates & Forecasts by Application 2018-2028 (USD Billion)
9.4. Heparin Market, Sub Segment Analysis
9.4.1. Venous Thromboembolism
9.4.2. Atrial Fibrillation
9.4.3. Renal Impairment
9.4.4. Coronary Artery Disease
9.4.5. Others
Chapter 10. Global Heparin Market, by End-Use
10.1. Market Snapshot
10.2. Global Heparin Market by End-Use, Performance – Potential Analysis
10.3. Global Heparin Market Estimates & Forecasts by End-Use 2018-2028 (USD Billion)
10.4. Heparin Market, Sub Segment Analysis
10.4.1. Outpatient
10.4.2. Inpatient
Chapter 11. Global Heparin Market, Regional Analysis
11.1. Heparin Market, Regional Market Snapshot
11.2. North America Heparin Market
11.2.1. U.S. Heparin Market
11.2.1.1. Type breakdown estimates & forecasts, 2018-2028
11.2.1.2. Source breakdown estimates & forecasts, 2018-2028
11.2.1.3. Route of Administration breakdown estimates & forecasts, 2018-2028
11.2.1.4. Application breakdown estimates & forecasts, 2018-2028
11.2.1.5. End-Use breakdown estimates & forecasts, 2018-2028
11.2.2. Canada Heparin Market
11.3. Europe Heparin Market Snapshot
11.3.1. U.K. Heparin Market
11.3.2. Germany Heparin Market
11.3.3. France Heparin Market
11.3.4. Spain Heparin Market
11.3.5. Italy Heparin Market
11.3.6. Rest of Europe Heparin Market
11.4. Asia-Pacific Heparin Market Snapshot
11.4.1. China Heparin Market
11.4.2. India Heparin Market
11.4.3. Japan Heparin Market
11.4.4. Australia Heparin Market
11.4.5. South Korea Heparin Market
11.4.6. Rest of Asia Pacific Heparin Market
11.5. Latin America Heparin Market Snapshot
11.5.1. Brazil Heparin Market
11.5.2. Mexico Heparin Market
11.6. Rest of The World Heparin Market

Chapter 12. Competitive Intelligence
12.1. Top Market Strategies
12.2. Company Profiles
12.2.1. Pfizer Inc
12.2.1.1. Key Information
12.2.1.2. Overview
12.2.1.3. Financial (Subject to Data Availability)
12.2.1.4. Type Summary
12.2.1.5. Recent Developments
12.2.2. LEO Pharma A/S
12.2.3. Dr. Reddy’s Laboratories Ltd.
12.2.4. GlaxoSmithKline plc
12.2.5. Sanofi
12.2.6. Aspen Holdings
12.2.7. Fresenius SE & Co. KGaA
12.2.8. B. Braun Medical, Inc.
12.2.9. Sandoz (Novartis AG)
12.2.10. Baxter International
Chapter 13. Research Process
13.1. Research Process
13.1.1. Data Mining
13.1.2. Analysis
13.1.3. Market Estimation
13.1.4. Validation
13.1.5. Publishing
13.2. Research Attributes
13.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now